Tag: Oncology
-

Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. Georgiamune to receive $45 million in upfront and near-term payments, as part of a total deal value of up to $1.1 billion, plus royalties.FLORENCE, Italy and GAIT…
-

NCCN Highlights Collaborations to Improve Global Cancer Outcomes During Meetings in North America and Asia
National Comprehensive Cancer Network participates in annual conferences for the International Gynecologic Cancer Society and Philippine Society of Medical Oncology in efforts to standardize cancer treatment recommendations.MONTREAL and MANILA, Philippines, Oct. 8, 2026 /PRNewswire/ — The National …










